Journal of Shanghai Jiao Tong University (Medical Science) >

2022 , Vol. 42 >Issue 4: 443 - 454

DOI: https://doi.org/10.3969/j.issn.1674-8115.2022.04.006

Basic research

Different roles of SMAD2 and SMAD3 in human embryonic stem cell differentiation

  • Bingnan ZHAO ,
  • Shuangyu MA ,
  • Chunlong XU ,
  • Qiong WANG
Expand
  • 1.Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Frontiers Science Center of Cellular Homeostasis and Human Disease, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2.Shanghai Center for Brain Science and Brain-Inspired Technology, Shanghai 200031, China
XU Chunlong, E-mail: larrylord@163.com.
WANG Qiong, E-mail: wangqiong@shsmu.edu.cn

Received date: 2022-01-19

  Accepted date: 2022-04-10

  Online published: 2022-04-28

Supported by

National Natural Science Foundation of China(31771512)

Fold

Abstract

Objective

·To investigate the different roles of SMAD proteins (drosophila mothers against decapentaplegic proteins)—SMAD2 and SMAD3, the major downstream effectors of the transforming growth factor β (TGFβ) family, in the differentiation process of human embryonic stem cells (hESCs) in vitro.

Methods

·The protein levels of SMAD2 and SMAD3 were measured by Western blotting in hESCs. The SMAD2 knockout (SMAD2KO) and SMAD3 knockout (SMAD3KO) cell lines were constructed in hESCs by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) technology. Immunofluorescence staining was used to detect the effect of SMAD protein loss on the expression of pluripotent factors octamer-binding transcription factor 4 (OCT4) and sex determining region Y-box 2 (SOX2), neuroectoderm (NE) factors paired box 6 (PAX6) and sex determining region Y-box 1 (SOX1), and mesendoderm (ME) factor SOX17. Flow cytometry was used to identify the expression changes of NE factor PAX6 and ME factor SOX17, eomesodermin (EOMES) and C-X-C motif chemokine receptor 4 (CXCR4) upon SMAD2 or SMAD3 loss. SMAD2 and SMAD3 plasmids were overexpressed in SMAD2KO and SMAD3KO cell lines, respectively, which were verified by Western blotting. Real-time quantitative reverse transcription PCR (qRT-PCR) was used to check whether the recoveries of SMAD proteins in SMADKO cell lines could restore the expression of ME key factors, like EOMES, forkhead box A2 (FOXA2) and goosecoid homeobox (GSC) during differentiation.

Results

·Although the protein sequences of SMAD2 and SMAD3 were similar, SMAD2 was the main factor expressed in hESCs. SMAD2 knockout and SMAD3 knockout did not affect the expression of pluripotent factors OCT4 and SOX2 from immunofluorescence staining results, nor the expression of NE factors PAX6 and SOX1 combined with flow cytometry results. SMAD3 knockout had no significant effect on the differentiation of hESCs into ME, while SMAD2 knockout severely hindered the expression of ME specific factors such as SOX17, EOMES and CXCR4. By qRT-PCR analysis, overexpression of exogenous SMAD2 in SMAD2KO cells can effectively restore the expression of ME genes including EOMES, FOXA2 and GSC, while replenishment of SMAD3 in SMAD3KO cells almost had no effect.

Conclusion

·SMAD2 and SMAD3 play different roles in the ME differentiation of hESCs. SMAD2, but not SMAD3, is critical for the expression of ME genes in hESCs.

Key words： human embryonic stem cell (hESC); mesendoderm differentiation; SMAD2; SMAD3

Cite this article

Bingnan ZHAO , Shuangyu MA , Chunlong XU , Qiong WANG . Different roles of SMAD2 and SMAD3 in human embryonic stem cell differentiation[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(4) : 443 -454 . DOI: 10.3969/j.issn.1674-8115.2022.04.006

References

1 DAVID C J, MASSAGUé J. Contextual determinants of TGFβ action in development, immunity and cancer[J]. Nat Rev Mol Cell Biol, 2018, 19(7): 419-435.
2 JIANG J M, NG H H. TGFβ and SMADs talk to NANOG in human embryonic stem cells[J]. Cell Stem Cell, 2008, 3(2): 127-128.
3 OSNATO A, BROWN S, KRUEGER C, et al. TGFβ signalling is required to maintain pluripotency of human na?ve pluripotent stem cells[J]. Elife, 2021, 10: e67259.
4 XU R H, SAMPSELL-BARRON T L, GU F, et al. NANOG is a direct target of TGFβ/activin-mediated SMAD signaling in human ESCs[J]. Cell Stem Cell, 2008, 3(2): 196-206.
5 VALLIER L, MENDJAN S, BROWN S, et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression[J]. Development, 2009, 136(8): 1339-1349.
6 WATABE T, MIYAZONO K. Roles of TGF-β family signaling in stem cell renewal and differentiation[J]. Cell Res, 2009, 19(1): 103-115.
7 TEO A K K, ARNOLD S J, TROTTER M W B, et al. Pluripotency factors regulate definitive endoderm specification through eomesodermin[J]. Genes Dev, 2011, 25(3): 238-250.
8 YANG J, JIANG W. The role of SMAD2/3 in human embryonic stem cells[J]. Front Cell Dev Biol, 2020, 8: 653.
9 ARAGóN E, WANG Q, ZOU Y L, et al. Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling[J]. Genes Dev, 2019, 33(21/22): 1506-1524.
10 NOMURA M, LI E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development[J]. Nature, 1998, 393(6687): 786-790.
11 WEINSTEIN M, YANG X, LI C, et al. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2[J]. Proc Natl Acad Sci USA, 1998, 95(16): 9378-9383.
12 ASHCROFT G S, YANG X, GLICK A B, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response[J]. Nat Cell Biol, 1999, 1(5): 260-266.
13 TREMBLAY K D, HOODLESS P A, BIKOFF E K, et al. Formation of the definitive endoderm in mouse is a Smad2-dependent process[J]. Development, 2000, 127(14): 3079-3090.
14 VINCENT S D, DUNN N R, HAYASHI S, et al. Cell fate decisions within the mouse organizer are governed by graded Nodal signals[J]. Genes Dev, 2003, 17(13): 1646-1662.
15 SAKAKI-YUMOTO M, LIU J M, RAMALHO-SANTOS M, et al. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state[J]. J Biol Chem, 2013, 288(25): 18546-18560.
16 LIU L, LIU X, REN X D, et al. Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification[J]. Sci Rep, 2016, 6: 21602.
17 GONZáLEZ F, ZHU Z R, SHI Z D, et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells[J]. Cell Stem Cell, 2014, 15(2): 215-226.
18 SANJANA N E, SHALEM O, ZHANG F. Improved vectors and genome-wide libraries for CRISPR screening[J]. Nat Methods, 2014, 11(8): 783-784.
19 WANG Q, ZOU Y L, NOWOTSCHIN S, et al. The p53 family coordinates Wnt and nodal inputs in mesendodermal differentiation of embryonic stem cells[J]. Cell Stem Cell, 2017, 20(1): 70-86.
20 D'AMOUR K A, AGULNICK A D, ELIAZER S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm[J]. Nat Biotechnol, 2005, 23(12): 1534-1541.
21 ZHU Z R, LI Q V, LEE K, et al. Genome editing of lineage determinants in human pluripotent stem cells reveals mechanisms of pancreatic development and diabetes[J]. Cell Stem Cell, 2016, 18(6): 755-768.
22 PENG G D, SUO S B, CHEN J, et al. Spatial transcriptome for the molecular annotation of lineage fates and cell identity in mid-gastrula mouse embryo[J]. Dev Cell, 2016, 36(6): 681-697.
23 PETERSEN M, PARDALI E, VAN DER HORST G, et al. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis[J]. Oncogene, 2010, 29(9): 1351-1361.
24 MALHOTRA N, ROBERTSON E, KANG J. SMAD2 is essential for TGF β-mediated Th17 cell generation[J]. J Biol Chem, 2010, 285(38): 29044-29048.
25 DUNN N R, KOONCE C H, ANDERSON D C, et al. Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile[J]. Genes Dev, 2005, 19(1): 152-163.
26 KIM S W, YOON S J, CHUONG E, et al. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs[J]. Dev Biol, 2011, 357(2): 492-504.
Options
Outlines

/

〈 〉